News Wire

Experts on the Zika virus outbreak have agreed on three top priorities for research into medical products, the World Health Organization (WHO) has reported. The WHO warned, however, that vaccine trials may come too late for the current outbreak. The top research priorities are: 1) tests for other viruses,…
French researchers have linked the Zika virus to the paralyzing disorder myelitis, according to a report posted on the Medical Xpress website. Zika virus infection is already suspected of causing microcephaly and brain damage in infants and Guillain–Barré syndrome in adults. A 15-year-old girl diagnosed…
Retail clinics, long seen as an antidote to more-expensive doctors’ offices and emergency rooms, may actually boost medical spending by leading consumers to get more care, according to a report from Kaiser Health News. A new study published in the March issue of Health Affairs has shown…
The National Osteoporosis Foundation (NOF), in a joint effort with the Pharmaceutical Research and Manufacturers of America, has released a report on new therapies being developed for the treatment of osteoporosis. The publication examines the nationwide effects of the disease and explores how new medications…
The International Consortium for Health Outcomes Measurement (ICHOM) has selected ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, to advance value-based health care through the launch of a global health care…
Researchers at Columbia University’s Mailman School of Public Health, with colleagues at the White House Social and Behavioral Sciences Team, the Massachusetts Institute of Technology, and the Centers for Medicare and Medicaid Services (CMS), have conducted a randomized trial of informative letters…
In an international study, researchers have found that the HOSPITAL score, an acronym created to identify the variables associated with hospital readmissions, successfully predicted patients at high risk of a 30-day potentially avoidable readmission. The researchers believe this score may help identify…
The FDA has given the nod to Idelvion (coagulation factor IX [recombinant], albumin fusion protein, CSL Behring), a long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of patients with hemophilia B. Idelvion is the first factor IX therapy…
New safety and efficacy data have shown that the risk–benefit profile generated through pivotal studies of mepolizumab (Nucala, GlaxoSmithKline) was maintained over 52 weeks. The study also demonstrated the exacerbation risk reduction, asthma control improvement, and oral corticosteroid dose reduction…
A data safety and monitoring board (DSMB) has determined that continuation of a phase 3 study of rindopepimut (Rintega, Celldex Therapeutics) in patients with newly diagnosed epidermal growth factor receptor vIII (EGFRvIII)-positive glioblastoma will not reach statistical significance for overall survival…
Patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept (Enbrel, Amgen) achieved significant improvement in their psoriasis plaques when treated with ixekizumab (Eli Lilly) in a phase 3 study. Results from the UNCOVER-2 trial were presented at the American…
New research indicates that another common mosquito may be able to carry the Zika virus, according to a Reuters report. The mosquito species Aedes aegypti is considered to be the main transmitter of Zika infections, but scientists in Brazil have announced that they were able to infect another species,…
The Centers for Disease Control and Prevention’s (CDC) latest Vital Signs report urges health care workers to use a combination of infection-control recommendations to better protect patients from health care-associated infections (HAIs). Many of the most serious antibiotic-resistant bacteria threaten…
Novo Nordisk has announced results from the LEADER trial, which investigated the cardiovascular safety of liraglutide (Victoza) during a period of up to five years in more than 9,000 adults with type-2 diabetes at high risk for major adverse cardiovascular events. The LEADER trial was an international,…
Marijuana use disorder is common in the U.S.; is often associated with other substance use disorders, behavioral problems, and disability; and goes largely untreated, according to a new study conducted by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes…

Pages